Google To Spend $250M To End Investor Suit Over Pharma Ads
Google Inc. has agreed to spend a total of $250 million on product quality control to end a suit brought by shareholders after its $500 million settlement with the U.S. government...To view the full article, register now.
Already a subscriber? Click here to view full article